SNDX Stock Price Today

SNDX Stock Quote and Chart

Track all markets on TradingView

SNDX News

Syndax (SNDX) Pharmaceuticals announced that data from the BEAT AML trial of revumenib in combinatio...
Clinical updates, including trial initiations, enrollment status and data readouts and publications:...
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 3.7% - Should You Sell?...
– Revumenib was generally well-tolerated in combination with venetoclax/azacitidine in older, newly ...
– 26% (20/77) CR+CRh rate and 48% (37/77) ORR in efficacy-evaluable pivotal R/R mNPM1 AML population...

SNDX Financials

SNDX Tech Analysis

SNDX Profile